LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

Kodu・Aktsiate loetelu・Medtronic PLC

Search

Medtronic PLC

Suletud

SektorTervishoid

76.02 -2.5

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

75.91

Max

77.22

Põhinäitajad
By Trading Economics
Sissetulek	-231M 1.1B
Müük	57M 9B
P/E Sektori keskmine	22.308 49.8
Aktsiakasum	1.36
Dividenditootlus	3.54
Kasumimarginaal	12.675
Töötajad	95,000
EBITDA	124M 2.5B

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+35.43% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	3.54% 2.25%
Järgmine tulemuste avaldamine	3. juuni 2026
Järgmine dividendimakse kuupäev	10. juuli 2026
Järgmine aktsia dividendi kuupäev (ex-date)	26. juuni 2026

Turustatistika
By TradingEconomics
Turukapital	-27B 101B
Eelmine avamishind	78.52
Eelmine sulgemishind	76.02

Uudiste sentiment

By Acuity

50%

50%

192 / 347 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bearish Evidence

83.26 / 84.875 Toetus ja vastupanu

Medtronic PLC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

10. märts 2026, 11:19 UTC

Omandamised, ülevõtmised, äriostud

Medtronic to Buy Scientia Vascular in $550 Million Deal

17. veebr 2026, 12:43 UTC

Tulu

Medtronic 3Q Profit Falls Despite Higher Revenue

3. veebr 2026, 13:53 UTC

Omandamised, ülevõtmised, äriostud

Medtronic to Acquire CathWorks in Deal Valued Up to $585 Million

22. apr 2026, 11:27 UTC

Tulu

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

20. apr 2026, 11:50 UTC

Omandamised, ülevõtmised, äriostud

Medtronic Completes Acquisition Of CathWorks, Expanding Its Leadership In Transforming Care For Patients With Cardiovascular Disease >MDT

24. märts 2026, 20:59 UTC

Tulu

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

10. märts 2026, 10:46 UTC

Omandamised, ülevõtmised, äriostud

Medtronic: Scientia Deal Complements Neurovascular Portfolio >MDT

10. märts 2026, 10:46 UTC

Omandamised, ülevõtmised, äriostud

Medtronic: Scientia Deal Includes Potential Undisclosed Earn-Out, Milestone Payments >MDT

10. märts 2026, 10:45 UTC

Omandamised, ülevõtmised, äriostud

Medtronic: Scientia Vascular Acquisition Valued at $550 Million >MDT

10. märts 2026, 10:45 UTC

Omandamised, ülevõtmised, äriostud

Medtronic to Acquire Scientia Vascular >MDT

17. veebr 2026, 21:21 UTC

Tulu

These Stocks Are Today's Movers: Paramount, Masimo, Medtronic, Kyndryl, eToro, Genuine Parts, Southwest, and More -- Barrons.com

17. veebr 2026, 18:11 UTC

Tulu

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17. veebr 2026, 14:48 UTC

Tulu

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17. veebr 2026, 13:00 UTC

Tulu

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17. veebr 2026, 12:05 UTC

Tulu

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17. veebr 2026, 11:47 UTC

Tulu

Medtronic Sees 2026 EPS up 4.5%, Excluding Potential Impact From Tariffs >MDT

17. veebr 2026, 11:47 UTC

Tulu

Medtronic Still Sees FY26 Organic Revenue Up About 5.5% >MDT

17. veebr 2026, 11:46 UTC

Tulu

Medtronic FY26 View Includes Potential Impact From Tariffs of About $185M >MDT

17. veebr 2026, 11:46 UTC

Tulu

Medtronic Backs FY26 View of Adj EPS $5.62-Adj EPS $5.66 >MDT

17. veebr 2026, 11:46 UTC

Tulu

Medtronic Reiterates FY26 Organic Rev Growth, EPS Guidance >MDT

17. veebr 2026, 11:45 UTC

Tulu

Medtronic 3Q Adj EPS $1.36 >MDT

17. veebr 2026, 11:45 UTC

Tulu

Medtronic 3Q Neuroscience Portfolio Rev $2.56B >MDT

17. veebr 2026, 11:45 UTC

Tulu

Medtronic 3Q Organic Revenue Up 6.0% >MDT

17. veebr 2026, 11:45 UTC

Tulu

Medtronic 3Q Sales $9.02B >MDT

17. veebr 2026, 11:45 UTC

Tulu

Medtronic 3Q Diabetes Rev $796M >MDT

17. veebr 2026, 11:45 UTC

Tulu

Medtronic 3Q Cardiovascular Portfolio Rev $3.46B >MDT

17. veebr 2026, 11:45 UTC

Tulu

Medtronic 3Q Medical Surgical Portfolio Rev $2.17B >MDT

17. veebr 2026, 11:45 UTC

Tulu

Medtronic 3Q Net $1.14B >MDT

17. veebr 2026, 11:45 UTC

Tulu

Medtronic 3Q EPS 89c >MDT

17. veebr 2026, 09:53 UTC

Kuumad aktsiad

Stocks to Watch Tuesday: Norwegian, Hyatt, Zim, Medtronic -- WSJ

Võrdlus sarnastega

Hinnamuutus

Medtronic PLC Prognoos

Hinnasiht

By TipRanks

35.43% tõus

12 kuu keskmine prognoos

Keskmine 105.58 USD 35.43%

Kõrge 120 USD

Madal 86 USD

Põhineb 21 Wall Streeti analüütiku instrumendi Medtronic PLC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

21 ratings

12

Osta

9

Hoia

0

Müü

Põhineb 21 analüütiku instrumendi Medtronic PLC aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

83.26 / 84.875Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bullish.

All events are bearish.

Sentiment

By Acuity

192 / 347 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

947.62

JNJ

Johnson and Johnson

221.12

ABBV

AbbVie Inc

201.14

UNH

UnitedHealth Group Inc

379.44

AZN

AstraZeneca PLC

182.32

Live chat